Skip to main content

MoneyWorks4Me

Marksans Pharma - Quaterly Results

05 Nov 2026 Evaluate
Revenue reduced marginally to stand at Rs. 3138.04 millions during the quarter ended September 2026. The figure stood at Rs. 3204.41 millions during the year-ago period.The Net Profit of the company registered a slight decline of -14.29% to Rs. 855.42  millions from Rs. 998.06 millions.Operating Profit reported a sharp decline to 1096.00 millions from 1302.64 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202609 202509 % Var 202609 202509 % Var 202603 202503 % Var
Sales 3138.04 3204.41 -2.07 6349.91 6401.75 -0.81 13414.76 11743.74 14.23
Other Income 572.43 581.89 -1.63 747.13 601.99 24.11 1035.33 657.87 57.38
PBIDT 1096.00 1302.64 -15.86 2091.74 2023.28 3.38 4271.00 2738.85 55.94
Interest 3.37 3.15 6.98 6.77 6.17 9.72 13.27 11.74 13.03
PBDT 1092.63 1299.49 -15.92 2084.97 2017.11 3.36 4257.73 2727.11 56.13
Depreciation 90.50 84.56 7.02 178.26 166.44 7.10 342.30 294.52 16.22
PBT 1002.13 1214.93 -17.52 1906.71 1850.67 3.03 3915.43 2432.59 60.96
TAX 146.71 216.87 -32.35 360.92 372.05 -2.99 908.45 549.87 65.21
Deferred Tax 9.63 8.82 9.18 10.04 18.62 -46.08 45.54 28.43 60.18
PAT 855.42 998.06 -14.29 1545.79 1478.62 4.54 3006.98 1882.72 59.71
Equity 453.16 453.16 0.00 453.16 453.16 0.00 453.16 453.16 0.00
PBIDTM(%) 34.93 40.65 -14.08 32.94 31.61 4.23 31.84 23.32 36.52
Peers
Company Name CMP
Sun Pharma. Inds. 1860.00
Dr. Reddys Labs. 1371.20
Cipla 1409.00
Lupin 1990.00
Zydus Lifesciences 1195.00
View more..